Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial update of CDC-501 therapy in relapsed or refractory multiple myeloma completed.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year [Phase 2]
Open-label extended access study of lenalidomide plus dexamethasone in Chinese patients with relapsed/refractory multiple myeloma who had at…
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Study of Subcutaneous and Intravenous Velcade in Combination With Dexamethasone in Chinese Subjects With Relapsed and Refractory Multiple Myeloma [Phase 3]
Phase 3 trial update evaluating subcutaneous and intravenous Velcade in combination with dexamethasone for Chinese patients with relapsed an…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating chemotherapy and peripheral stem cell transplantation followed by immunotherapy for multiple myeloma; st…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib [Phase 2]
Phase 2 trial update on using glutamine to prevent peripheral neuropathy in patients with multiple myeloma treated with bortezomib; study st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating lenalidomide and high-dose melphalan followed by autologous stem cell transplant in multiple myeloma has complete…
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma [Phase 2, Phase 3]
A phase 2/3 clinical trial comparing thalidomide 100 mg/day versus 400 mg/day in relapse-refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating peripheral stem cell transplantation with combination chemotherapy in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating oblimersen, thalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating peripheral stem cell transplantation with combination chemotherapy in patients with multiple myeloma has c…
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating bone marrow transplantation from fully matched relatives as donors for hematologic malignancies has completed; resu…
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma [Phase 4]
A Phase 4 trial evaluating lenalidomide and dexamethasone with or without stem cell transplant in patients with multiple myeloma has complet…
-
CLINICAL_TRIALS trial_result · 2019-10-14Clinical Trial Update: Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma [Phase 1]
Phase 1 trial evaluating total marrow irradiation with high-dose melphalan before autologous transplant in multiple myeloma; the study statu…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma [Phase 2]
Phase 2 trial evaluating activated marrow-infiltrating lymphocytes alone or with an allogeneic GM-CSF-based myeloma vaccine in autologous tr…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma [Phase 1]
Phase 1 trial evaluating T cells targeting B-cell maturation antigen (BCMA) in previously treated multiple myeloma has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916 [Phase 1]
Phase 1 dose-escalation study evaluating safety, PK/PD, immunogenicity, and clinical activity of GSK2857916 in adults with multiple myeloma;…
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma [Phase 2]
Phase 2 trial evaluating bortezomib with pegylated liposomal doxorubicin in previously untreated symptomatic multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications [Phase 1, Phase 2]
A dose-escalation Phase I study is evaluating safety and preliminary activity of a multi-indication cancer therapy in acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma [Phase 1, Phase 2]
A clinical trial update describes a multi-CAR T cell therapy being studied for multiple myeloma across Phase 1 and Phase 2, with the status …
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Study of Lenalidomide and Dexamethasone With or Without Pembrolizumab (MK-3475) in Participants With Newly Diagnosed Treatment Naive Multiple Myeloma (MK-3475-185/KEYNOTE-185) [Phase 3]
Phase 3 trial of lenalidomide and dexamethasone with or without pembrolizumab in newly diagnosed multiple myeloma was terminated.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Daratumumab in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial update of daratumumab in patients with plasma cell myeloma (Multiple Myeloma) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma [Phase 2]
Phase 2 SWOG S1304 evaluated the combination of carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma; resu…
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma [Phase 2]
Phase 2 trial evaluating daratumumab in combination with DCEP for relapsed multiple myeloma with plasmacytoma.
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Clinical Trial of Clarithromycin, Lenalidomide and Dexamethasone in the Treatment of the First Relapsed Multiple Myeloma [Phase 2]
Phase 2 clinical trial investigating clarithromycin, lenalidomide, and dexamethasone in relapsed multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2019-08-16Clinical Trial Update: A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) [Phase 2]
Phase 2 clinical trial investigating patients with smoldering and active multiple myeloma is currently enrolling by invitation.